CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Synaptogenix, Inc. - SNPX CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 0.80-8.75
平均交易量(10 天) 70.74K
平均交易量(3 个月) 1.84M
市值 6.10M
市盈率 -100.00K
流通股 6.85M
收入 N/A
EPS -2.07
股息(收益率 %) N/A
贝塔 -100.00K
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Synaptogenix, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018
总收入 0 0 0 0
总营业费用 12.6183 12.8564 15.5135 11.1494
销售/一般/行政费用,总计 8.28189 8.08738 10.9725 6.26383
研究与开发 4.33641 3.06903 4.54095 4.88556
营业收入 -12.6183 -12.8564 -15.5135 -11.1494
利息收入(费用),非经营净值 0.00711 0.15321 0.37871 0.12711
税前净收入 -12.6112 -12.7032 -15.1348 -11.0223
税后净收入 -12.6112 -12.7032 -15.1348 -11.0223
未计算非常项目前的净收益 -12.6112 -12.7032 -15.1348 -11.0223
净收入 -12.6112 -12.7032 -15.1348 -11.0223
普通股股东可获收益 (不含非经常性项目) -12.6112 -15.1302 -15.1348 -11.0223
普通股股东可获收益 (含非經常性項目) -12.6112 -15.1302 -15.1348 -11.0223
摊薄净收入 -12.6112 -15.1302 -15.1348 -11.0223
摊薄后加权平均股 5.0151 1.25758 1.32211 1.32211
扣除特别项目的每股摊薄盈利 -2.51465 -12.0312 -11.4474 -8.33687
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -2.51465 -10.6794 -11.4474 -8.33687
异常费用(收入) 0 1.7
Total Adjustments to Net Income -2.427
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
总营业费用 3.28253 4.23856 2.92938 2.29517 3.15519
销售/一般/行政费用,总计 1.79646 2.87693 2.09266 1.30889 2.00341
研究与开发 1.48607 1.36164 0.83672 0.98628 1.15178
营业收入 -3.28253 -4.23856 -2.92938 -2.29517 -3.15519
利息收入(费用),非经营净值 0.00461 0.00252 0.00245 0.00133 0.00082
税前净收入 -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
税后净收入 -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
未计算非常项目前的净收益 -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
净收入 -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
普通股股东可获收益 (不含非经常性项目) -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
普通股股东可获收益 (含非經常性項目) -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
摊薄净收入 -3.27792 -4.23605 -2.92693 -2.29384 -3.15438
摊薄后加权平均股 6.9392 6.7998 6.1966 3.9712 2.96903
扣除特别项目的每股摊薄盈利 -0.47238 -0.62297 -0.47234 -0.57762 -1.06243
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.47238 -0.62297 -0.47234 -0.57762 -1.06243
异常费用(收入) 0
  • 年度
  • 每季度
2021 2020 2019 2018
流动资产总额 35.5042 6.72879 17.8762 29.4575
现金和短期投资 34.214 5.79506 17.382 28.8542
现金等价物 34.214 5.79506 17.382 28.8542
Prepaid Expenses 1.29023 0.80629 0.49411 0.60332
Total Assets 35.5247 6.751 17.8978 29.4784
Property/Plant/Equipment, Total - Net 0.02045 0.02221 0.02167 0.02084
Total Current Liabilities 1.99491 1.61249 0.47906 2.95708
Accounts Payable 1.29651 1.26034 0.41308 2.89858
Accrued Expenses 0.69841 0.35215 0.06598 0.05849
Notes Payable/Short Term Debt 0 0 0 0
Total Liabilities 1.99491 1.61249 0.47906 2.95708
Total Long Term Debt 0 0 0 0
Total Equity 33.5298 5.13851 17.4188 26.5213
Common Stock 0.00067 0.0005 0.00131 0.00129
Additional Paid-In Capital 47.6707 6.66848 106.234 100.202
Retained Earnings (Accumulated Deficit) -14.1417 -1.53047 -88.8168 -73.6821
Total Liabilities & Shareholders’ Equity 35.5247 6.751 17.8978 29.4784
Total Common Shares Outstanding 6.73018 1.25758 1.32211 1.32211
应收账款总额,净额 0.12745
Other Equity, Total 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 32.3342 35.5042 32.3402 32.9402 16.3257
现金和短期投资 31.2817 34.214 31.2946 31.7021 14.8484
现金等价物 31.2817 34.214 31.2946 31.7021 14.8484
应收账款总额,净额 0 0
Prepaid Expenses 1.05247 1.29023 1.04551 1.23816 1.47723
Total Assets 32.3533 35.5247 32.3586 32.96 16.3466
Property/Plant/Equipment, Total - Net 0.01913 0.02045 0.01849 0.01973 0.02097
Total Current Liabilities 0.66934 1.99491 1.00733 0.76997 0.93744
Accounts Payable 0.40135 1.29651 0.93538 0.64816 0.75896
Accrued Expenses 0.26799 0.69841 0.07195 0.12181 0.17848
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 0.66934 1.99491 1.00733 0.76997 0.93744
Total Long Term Debt 0 0 0 0 0
Total Equity 31.684 33.5298 31.3513 32.19 15.4092
Common Stock 0.00068 0.00067 0.00062 0.0006 0.0014
Additional Paid-In Capital 49.1029 47.6707 41.2563 39.1681 20.0927
Retained Earnings (Accumulated Deficit) -17.4196 -14.1417 -9.90563 -6.97869 -4.68485
Total Liabilities & Shareholders’ Equity 32.3533 35.5247 32.3586 32.96 16.3466
Total Common Shares Outstanding 6.80965 6.73018 6.13697 6.0388 3.50813
  • 年度
  • 每季度
2021 2020 2019 2018
净收入/起跑线 -12.6112 -12.7032 -15.1348 -11.0223
经营活动产生的现金 -8.71073 -8.1024 -11.8868 -7.69677
经营活动产生的现金 0.00497 0.00487 0.00439 0.003
非现金物品 3.86958 3.90212 5.61236 2.21661
营运资金的变化 0.02593 0.69381 -2.36881 1.10591
投资活动产生的现金 -0.0032 -0.00541 -0.00521 -0.00319
资本支出 -0.0032 -0.00541 -0.00521 -0.00319
融资活动产生的现金 37.1329 -3.47917 0.41984 20.441
股票的发行(报废),净额 37.1344 16.5242 0.41984 20.441
现金净变化 28.4189 -11.587 -11.4722 12.7411
融资现金流项目 -0.00153 -20.0034
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -3.27792 -12.6112 -8.37515 -5.44822 -3.15438
Cash From Operating Activities -3.48541 -8.71073 -6.66556 -5.58532 -3.58672
Cash From Operating Activities 0.00132 0.00497 0.00373 0.00249 0.00125
Non-Cash Items 0.87901 3.86958 2.4228 1.1348 0.91241
Changes in Working Capital -1.08781 0.02593 -0.71694 -1.27439 -1.34599
Cash From Investing Activities -0.0032 0 0 0
Capital Expenditures -0.0032 0 0 0
Cash From Financing Activities 0.55315 37.1329 32.1651 31.4923 12.6401
Financing Cash Flow Items 0 -0.00153 -0.00153 0.12592 0.12745
Issuance (Retirement) of Stock, Net 0.55315 37.1344 32.1667 31.3664 12.5127
Net Change in Cash -2.93226 28.4189 25.4996 25.907 9.0534
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Alpha Capital Aktiengesellschaft Holding Company 4.1055 301977 -29305 2021-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.0271 222654 159 2022-12-31 LOW
Intracoastal Capital, L.L.C. Corporation 2.4304 178765 178365 2022-12-31 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8472 62316 -159 2022-12-31 LOW
Perry (George) Individual Investor 0.5438 40000 40000 2021-07-13
Silverman (Joshua) Individual Investor 0.5199 38238 33238 2022-12-20 LOW
Alkon (Daniel L M.D.) Individual Investor 0.4833 35547 34062 2022-12-20
Citadel Advisors LLC Hedge Fund 0.4655 34238 34238 2022-12-31 HIGH
Weinstein (Robert) Individual Investor 0.4513 33198 33000 2022-12-20 HIGH
Singer (William S) Individual Investor 0.4487 33000 33000 2022-12-20 HIGH
Tuchman (Alan J) Individual Investor 0.4487 33000 33000 2022-12-20 LOW
Cannell & Co. Investment Advisor 0.4079 30000 -46220 2022-12-31 LOW
Bernstein (Bruce T.) Individual Investor 0.3749 27578 27500 2022-12-20 LOW
Schechter (Jonathan L) Individual Investor 0.3705 27250 24750 2022-12-20 HIGH
Diametric Capital Investment Advisor/Hedge Fund 0.3609 26549 -1172 2022-09-30 HIGH
Platform Technology Partners LLC Investment Advisor 0.3418 25138 9106 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2733 20100 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2065 15188 348 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.1835 13500 -3000 2022-12-31 HIGH
Advisor Group, Inc Investment Advisor 0.1244 9148 8600 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Synaptogenix, Inc. Company profile

关于 Synaptogenix Inc

Synaptogenix公司,前身为Neurotrope生物科学公司,是一家生物制药公司。 该公司主要致力于为神经退行性疾病和发育障碍患者开发治疗方法。 公司正在开发一个基于候选药物Bryostatin-1的产品平台,该药物是由一种从海洋无脊椎生物中分离出来的天然产品(ryostatin)合成的,用于治疗阿尔茨海默病(AD)。 其主要候选产品是 Bryostatin-1。 Bryostatin-1是一种蛋白激酶C Epsilon(PKC e),是一种和e激活剂,最初被开发为潜在的抗癌药物。 该公司还在评估 Bryostatin在其他神经退行性或认知性疾病和功能障碍方面的治疗应用,如脆性X综合征、多发性硬化症和Niemann-Pick C型疾病,这些都已进行了临床前测试。

Industry: Biotechnology & Medical Research (NEC)

1185 Avenue Of The Americas, 3Rd Floor
NEW YORK
NEW YORK 10036
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0025%
隔夜费时间 21:00 (UTC)
价差 0.03

XRP/USD

0.45 Price
-1.190% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00377

US100

12,798.80 Price
+0.420% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 3.0

Gold

1,978.85 Price
-0.760% 1D Chg, %
多头隔夜费 -0.0179%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易